Pharma news
Americas
US law firm Wolf Greenfield has promoted Jenny Chen, Thomas Franklin and Jessamine Lee to shareholders. 27 January 2016
Americas
Law firm Lerner David Littenberg Krumholz & Mentlik has hired Tedd Van Buskirk as partner in its intellectual property practice in Westfield, New Jersey. 26 January 2016
Africa
Pharmaceutical companies including Cipla and Natco Pharma have signed a sub-licensing deal enabling them to produce a generic version of Bristol Myers Squibb’s hepatitis C drug Daclatasvir. 26 January 2016
Americas
The US Court of Appeals for the Federal Circuit has rejected Pfizer’s plea to extend the term of a patent centring on cancer treatment, upholding a lower court’s ruling that cleared the US Patent and Trademark Office of wrongdoing. 25 January 2016
Americas
The US government has charged five Chinese scientists with conspiring to steal confidential research into anti-cancer drugs belonging to pharmaceutical company GSK. 22 January 2016
Americas
Law firm Hogan Lovells has hired Michael Dougherty and Tony Pezzano as partners in the firm’s intellectual property media and technology practice group in New York. 21 January 2016
Americas
Despite the current unfavourable climate, there is still reason to be optimistic about patenting diagnostic method claims in the US, particularly if the claim is focused on a particular disease, biomarker, and/or treatment and includes an active step that applies the diagnostic information, says Kevin O’Connor of Neal, Gerber & Eisenberg. 21 January 2016
Africa
An individual working at India-based healthcare organisation Micro Labs has launched a mobile app which obtains relevant data on patents for pharmaceutical and biotechnology industry professionals. 18 January 2016
Pharma
The English High Court has ruled that the US branch of pharmaceutical company Merck Sharp & Dohme’s use of the ‘Merck’ trademark violated a previous agreement with its German rival. 15 January 2016
Pharma
A unitary supplementary protection certificate looks like a logical and desirable extension of the unitary patent system, and right owners and practitioners need to keep an eye on developments in EU regulation, as Andrew Webb and Graham Lewis of J A Kemp describe. 14 January 2016